<DOC>
	<DOCNO>NCT01968850</DOCNO>
	<brief_summary>This two-site , three-arm , open-label , pilot randomize control trial bone anti-resorptive therapy ART initiation HIV-infected adult . Thirty ( 30 ) treatment-naïve HIV-infected adult initiate eligible first-line ART regimens randomize 1:1:1 fashion one follow three arm : 1. bone anti-resorptive therapy ( standard care ) 2. concomitant initiation 24 week course co-formulated alendronate/vitamin D ; 3. 24 week delay initiation 24 week course alendronate/vitamin D Assessments ( include clinical evaluation , questionnaire , adherence , basic laboratory evaluation , BMD measurement ) perform baseline , 24 48 week . The primary objective involve calculation σ ρ use data ; δ estimate compare two alendronate arm pool no-treatment arm .</brief_summary>
	<brief_title>Bone Antiresorptive Therapy With Antiretroviral Initiation ( BATARI ) Pilot Trial</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Documented HIV1 infection Adult ( age &gt; 18 year per local guideline ) Premenopausal , female Antiretroviralnaïve Starting firstline ART include tenofovir/emtricitabine either efavirenz ( coformulated Atripla® ) elvitegravir , cobicistat ( coformulated Stribild® ) Low ( &lt; 10 % ) tenyear fracture risk assess FRAX score validate Canadian population Presence establish osteoporosis baseline determine BMD measurement Prior current use bone antiresorptive therapy ( eg . bisphosphonate , estrogens exception oral contraceptive pill , etc . ) Inability communicate English Creatinine clearance &lt; 35 mL/min ( use CockcroftGault formula ) Hypersensitivity alendronate , bisphosphonates , component formulation Hypocalcemia Abnormalities esophagus delay esophageal empty stricture achalasia Inability stand sit upright least 30 minute Pregnancy , active plan become pregnant , lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>HIV</keyword>
	<keyword>bone Mineral Density</keyword>
	<keyword>alendronate</keyword>
	<keyword>vitamin D</keyword>
</DOC>